Check Point Software Technologies (CHKP) Earnings Analysis
Check Point Software Technologies (CHKP) next reports earnings on 2026-07-30, consensus EPS 2.45 USD. Last quarter (2026-04-30) it beat with EPS 2.5 USD vs 2.41 USD est (+3.7%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 12.91.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CHKP next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 2.45 USD |
| Revenue estimate | 0.68B |
CHKP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 2.5 USD | 2.41 USD | +3.7% | Beat |
| 2026-02-12 | 3.4 USD | 2.77 USD | +22.7% | Beat |
| 2025-01-30 | 2.7 USD | 2.66 USD | +1.5% | Beat |
| 2024-07-24 | 2.17 USD | 2.16 USD | +0.5% | Beat |
Beat rate: 4/4 (100%) over reported quarters with consensus data.
CHKP valuation and analyst view
| Trailing P/E | 12.91 |
|---|---|
| Trailing EPS | 10.101 USD |
| Price / book | 4.76 |
| Dividend yield | 0.00% |
| Market cap | 13.32B |
| Analyst consensus | Hold (28 buy / 30 hold / 5 sell) |
| Avg price target | 146.45 USD |
Related research pages
Frequently asked questions
When is Check Point Software Technologies (CHKP)'s next earnings date?
Check Point Software Technologies is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 2.45 USD and revenue estimate of 0.68B.
Did CHKP beat earnings last quarter?
In its 2026-04-30 report, CHKP posted EPS of 2.5 USD versus a 2.41 USD estimate — a beat of 3.7%.
What is CHKP's earnings track record?
Over the last 4 reported quarters with consensus data, CHKP beat estimates 4 times (100%).
What is CHKP's current P/E ratio and EPS?
CHKP trades at a trailing P/E of 12.91 on trailing EPS of 10.10124164278892 USD.
What do analysts rate CHKP?
Analyst consensus is "Hold" across 63 ratings (0 strong buy, 28 buy, 30 hold, 5 sell, 0 strong sell). Average 12-month price target: 146.45 USD.